Dynein Light Chain Roadblock-Type 2 Human Recombinant, DYNLRB2 Human, 20ug
Dynein Light Chain Roadblock-Type 2 Human Recombinant, DYNLRB2 Human, 20ug
| CAT No.BT-PRO-174 | 
| Dynein Light Chain Roadblock-Type 2 Human Recombinant, DYNLRB2 Human, 20ug | 
Amino acid sequence
MGSSHHHHHH SSGLVPRGSH MAEVEETLKR IQSHKGVIGT MVVNAEGIPI RTTLDNSTTV QYAGLLHHLT MKAKSTVRDI DPQNDLTFLR IRSKKHEIMV APDKEYLLIV IQNPCE.
Description
DYNLRB2 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 116 amino acids (1-96 a.a.) and having a molecular mass of 13kDa. The DYNLRB2 is purified by proprietary chromatographic techniques.
Formulation
The DYNLRB2 solution (0.5 mg/ml) contains 20mM Tris-HCl buffer (pH8.0), 20% glycerol, 0.1M NaCl and 1mM DTT.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Source
Escherichia Coli.
Stability
DYNLRB2 should be stored desiccated below -18¡ãC. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). 
Please prevent freeze-thaw cycles.
Synonyms
Dynein light chain roadblock-type 2, Dynein light chain 2B cytoplasmic, Roadblock domain-containing protein 2, DYNLRB2, DNCL2B, DNLC2B, ROBLD2, MGC62033.
Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
                      
                        
                        
                          Product features
                        
                      
                    Product features
                      
                        
                        
                          Materials and care
                        
                      
                    Materials and care
                      
                        
                        
                          Merchandising tips
                        
                      
                    Merchandising tips
Share
 
 

 
               
     
    